Table 2 Prevalence of side effects in rHNC patients undergoing CT-guided RISI after two or more courses of radiotherapy (n = 33)
Cases | Percentage | |
|---|---|---|
Puncture-related adverse reaction | ||
Bleeding | 0 | |
Enhanced pain | 3 | 9.1% |
Infection | 0 | |
Skin non-union | 0 | |
Implantation metastasis | 0 | |
Radiation-related adverse reaction | ||
Early skin reaction | ||
I | 1 | 3.0% |
II | 2 | 6.1% |
III | 0 | |
IV | 0 | |
Late skin reaction | ||
I | 0 | |
II | 1 | 3.0% |
III | 1 | 3.0% |
IV | 0 | |
Early mucosal reaction | ||
I | 1 | 3.0% |
II | 3 | 9.1% |
III | 0 | |
IV | 0 | |
Late mucosal reaction | 0 | |
Blood toxicity | 0 | |
Enhanced xerostomia | 0 | |
Radiation myelitis | 0 | |
Radiation-based nerve injury | 0 | |
Mandibular osteonecrosis | 1 | 3.0% |
Seed migration | 0 | |